ANTARES PHARMA, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 1979-01-01
- Employees
- 201
- Market Cap
- -
- Website
- http://www.antarespharma.com
Clinical Trials
9
Active:0
Completed:9
Trial Phases
3 Phases
Phase 1:3
Phase 2:3
Phase 3:3
Drug Approvals
5
FDA:5
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (33.3%)Phase 2
3 (33.3%)Phase 3
3 (33.3%)Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Phase 2
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2016-05-19
- Last Posted Date
- 2018-03-22
- Lead Sponsor
- Antares Pharma Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT02777242
Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism
Phase 3
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- Antares Pharma Inc.
- Target Recruit Count
- 133
- Registration Number
- NCT02504541
Pharmacokinetic Study of Subcutaneous Testosterone Enanthate
Phase 1
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2014-09-08
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- Antares Pharma Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02233751
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
Phase 3
Completed
- Conditions
- Hypogonadism
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2018-02-07
- Lead Sponsor
- Antares Pharma Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT02159469
Pharmacokinetic Study of Testosterone Enanthate
Phase 1
Completed
- Conditions
- Hypogonadism
- Interventions
- Drug: QuickShot™ - 100 mg Treatment ADrug: QuickShot™ - 50 mg Treatment B
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2018-01-11
- Lead Sponsor
- Antares Pharma Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT01887418
- Locations
- 🇺🇸
Mens Health Boston, Brookline, Massachusetts, United States
- Prev
- 1
- 2
- Next
News
No news found